BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 34571917)

  • 1. Overexpression of the Ubiquitin Specific Proteases USP43, USP41, USP27x and USP6 in Osteosarcoma Cell Lines: Inhibition of Osteosarcoma Tumor Growth and Lung Metastasis Development by the USP Antagonist PR619.
    Lavaud M; Mullard M; Tesfaye R; Amiaud J; Legrand M; Danieau G; Brion R; Morice S; Regnier L; Dupuy M; Brounais-Le Royer B; Lamoureux F; Ory B; Rédini F; Verrecchia F
    Cells; 2021 Aug; 10(9):. PubMed ID: 34571917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ubiquitin-specific proteases as therapeutic targets in paediatric primary bone tumours?
    Mullard M; Lavaud M; Regnier L; Tesfaye R; Ory B; Rédini F; Verrecchia F
    Biochem Pharmacol; 2021 Dec; 194():114797. PubMed ID: 34678225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrophage migration inhibitory factor promotes osteosarcoma growth and lung metastasis through activating the RAS/MAPK pathway.
    Wang C; Zhou X; Li W; Li M; Tu T; Ba X; Wu Y; Huang Z; Fan G; Zhou G; Wu S; Zhao J; Zhang J; Chen J
    Cancer Lett; 2017 Sep; 403():271-279. PubMed ID: 28642171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tegavivint and the β-Catenin/ALDH Axis in Chemotherapy-Resistant and Metastatic Osteosarcoma.
    Nomura M; Rainusso N; Lee YC; Dawson B; Coarfa C; Han R; Larson JL; Shuck R; Kurenbekova L; Yustein JT
    J Natl Cancer Inst; 2019 Nov; 111(11):1216-1227. PubMed ID: 30793158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of Estrogen Receptor Alpha by Decitabine Inhibits Osteosarcoma Growth and Metastasis.
    Lillo Osuna MA; Garcia-Lopez J; El Ayachi I; Fatima I; Khalid AB; Kumpati J; Slayden AV; Seagroves TN; Miranda-Carboni GA; Krum SA
    Cancer Res; 2019 Mar; 79(6):1054-1068. PubMed ID: 30593524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TH1579, MTH1 inhibitor, delays tumour growth and inhibits metastases development in osteosarcoma model.
    Moukengue B; Brown HK; Charrier C; Battaglia S; Baud'huin M; Quillard T; Pham TM; Pateras IS; Gorgoulis VG; Helleday T; Heymann D; Berglund UW; Ory B; Lamoureux F
    EBioMedicine; 2020 Mar; 53():102704. PubMed ID: 32151797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting Super-Enhancer-Associated Oncogenes in Osteosarcoma with THZ2, a Covalent CDK7 Inhibitor.
    Zhang J; Liu W; Zou C; Zhao Z; Lai Y; Shi Z; Xie X; Huang G; Wang Y; Zhang X; Fan Z; Su Q; Yin J; Shen J
    Clin Cancer Res; 2020 Jun; 26(11):2681-2692. PubMed ID: 31937612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Thioredoxin Reductase Inhibitor Auranofin Suppresses Pulmonary Metastasis of Osteosarcoma, But Not Local Progression.
    Kinoshita H; Shimozato O; Ishii T; Kamoda H; Hagiwara Y; Tsukanishi T; Ohtori S; Yonemoto T
    Anticancer Res; 2021 Oct; 41(10):4947-4955. PubMed ID: 34593442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Euxanthone Impairs the Metastatic Potential of Osteosarcoma by Reducing COX-2 Expression.
    Chen X; Deng M; Zhou X; Wang X; Ye Y; Zhu J; Jiang H; Chen X; Zha W
    Anat Rec (Hoboken); 2019 Aug; 302(8):1399-1408. PubMed ID: 30334373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-382 inhibits osteosarcoma metastasis and relapse by targeting Y box-binding protein 1.
    Xu M; Jin H; Xu CX; Sun B; Song ZG; Bi WZ; Wang Y
    Mol Ther; 2015 Jan; 23(1):89-98. PubMed ID: 25292190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneous expression and biological function of ubiquitin carboxy-terminal hydrolase-L1 in osteosarcoma.
    Zheng S; Qiao G; Min D; Zhang Z; Lin F; Yang Q; Feng T; Tang L; Sun Y; Zhao H; Li H; Yu W; Yang Y; Shen Z; Yao Y
    Cancer Lett; 2015 Apr; 359(1):36-46. PubMed ID: 25578779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-491 Inhibits Osteosarcoma Lung Metastasis and Chemoresistance by Targeting αB-crystallin.
    Wang SN; Luo S; Liu C; Piao Z; Gou W; Wang Y; Guan W; Li Q; Zou H; Yang ZZ; Wang D; Wang Y; Xu M; Jin H; Xu CX
    Mol Ther; 2017 Sep; 25(9):2140-2149. PubMed ID: 28648665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gelsolin promotes cell growth and invasion through the upregulation of p-AKT and p-P38 pathway in osteosarcoma.
    Ma X; Sun W; Shen J; Hua Y; Yin F; Sun M; Cai Z
    Tumour Biol; 2016 Jun; 37(6):7165-74. PubMed ID: 26662962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chloroquine suppresses proliferation and invasion and induces apoptosis of osteosarcoma cells associated with inhibition of phosphorylation of STAT3.
    Chen C; Zhang H; Yu Y; Huang Q; Wang W; Niu J; Lou J; Ren T; Huang Y; Guo W
    Aging (Albany NY); 2021 Jun; 13(13):17901-17913. PubMed ID: 34170850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Furowanin A Exhibits Antiproliferative and Pro-Apoptotic Activities by Targeting Sphingosine Kinase 1 in Osteosarcoma.
    Wei K; Sun H; Chen X; Chen Q; Li Y; Wu H
    Anat Rec (Hoboken); 2019 Nov; 302(11):1941-1949. PubMed ID: 31197942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA‑487b‑3p inhibits osteosarcoma chemoresistance and metastasis by targeting ALDH1A3.
    Cheng M; Duan PG; Gao ZZ; Dai M
    Oncol Rep; 2020 Dec; 44(6):2691-2700. PubMed ID: 33125503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Fas/FasL Signaling Pathway: Its Role in the Metastatic Process and as a Target for Treating Osteosarcoma Lung Metastases.
    Koshkina N; Yang Y; Kleinerman ES
    Adv Exp Med Biol; 2020; 1258():177-187. PubMed ID: 32767242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PLK2 modulation of enriched TAp73 affects osteogenic differentiation and prognosis in human osteosarcoma.
    Li W; Zhang X; Xi X; Li Y; Quan H; Liu S; Wu L; Wu P; Lan W; Shao Y; Li H; Chen K; Hu Z
    Cancer Med; 2020 Jun; 9(12):4371-4385. PubMed ID: 32349184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crosstalk between ATF4 and MTA1/HDAC1 promotes osteosarcoma progression.
    Zeng H; Zhang JM; Du Y; Wang J; Ren Y; Li M; Li H; Cai Z; Chu Q; Yang C
    Oncotarget; 2016 Feb; 7(6):7329-42. PubMed ID: 26797758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticancer activity of halofuginone in a preclinical model of osteosarcoma: inhibition of tumor growth and lung metastases.
    Lamora A; Mullard M; Amiaud J; Brion R; Heymann D; Redini F; Verrecchia F
    Oncotarget; 2015 Jun; 6(16):14413-27. PubMed ID: 26015407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.